Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
  • Primary Care
  • Infectious Disease
  • Pharmacology CE
  • 1.25 Contact hours
$25.00
1.25 NAPNAP Contact Hour of which 1.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is an archived presentation from NAPNAP's 2023 National Conference. Antibiotics are the most commonly prescribed medications in pediatrics. This presentation will review current antibiotic resistance patterns and provide a rapid-fire review of current guidelines for prescribing antibiotics for pediatric patients.
  • Primary Care
  • FREE for Members
  • Immunization
  • Pharmacology CE
  • 1.25 Contact hours
$12.50
1.25 NAPNAP Contact Hour of which 1.25 contain pharmacology content. This continuing education activity is free for NAPNAP Members. For non-members, this continuing education activity rate is $12.50. While presenting the latest CDC immunization information, Dr. Koslap-Petraco will share real life experiences and case studies to engage and challenge you to educate and vaccinate your patient families, especially those who question the need for vaccines.
  • Primary Care
  • Acute Care
  • 1.00 Contact hours
$20.00
Exclusive benefit – This course is free for NAPNAP members through the month of May 2024 1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is an archived presentation from NAPNAP's 2023 National Conference and is offered free with a coupon for conference attendees until 12/31/23. Research shows that early identification of child physical abuse reduces the rate of subsequent injury and death by up to 50%, yet children are not consistently screened for physical abuse due to insufficient provider knowledge and lack of a systematic screening protocol. This presentation will provide an overview of child physical abuse, including red flags and injuries that are suspicious for abuse. Using interactive case studies, participants will learn how to utilize the validated Escape instrument to screen and identify children at high risk for physical abuse. The presenter will also review an example screening protocol, important documentation guidelines and screening considerations for acute and primary care NPs across a variety of pediatric settings.
  • Primary Care
  • 1.00 Contact hours
$0.00
New insights into the immunopathology of FA have led to development of cautious use of controlled exposure to food allergens through allergen immunotherapy and emerging use of monoclonal antibody therapy to interfere with the synthesis of immunoglobulin E (IgE). The expert faculty will contextualize the mechanisms and available clinical trial data related to the use of biologic agents in FA as monotherapy and as adjunct therapy to allergen immunotherapy.

Pages